TABLE IV.
Mean Treatment Effect (95% CI*) | ||||
Outcome Scale | 1 Year | 2 Years | 3 Years | 4 Years |
SF-36 bodily pain | ||||
Patients with symptoms for ≤6 months | 15.6 (12.1 to 19) | 12.8 (9.3 to 16.3) | 13.6 (10 to 17.3) | 16.5 (12.8 to 20.3) |
Patients with symptoms for >6 months | 17.5 (12.1 to 22.9) | 17.7 (12.2 to 23.2) | 18 (12.1 to 23.9) | 20.6 (14.5 to 26.6) |
P value | 0.55 | 0.14 | 0.21 | 0.26 |
SF-36 physical function | ||||
Patients with symptoms for ≤6 months | 20 (16.8 to 23.3) | 16.8 (13.5 to 20.1) | 16.8 (13.4 to 20.2) | 18.2 (14.7 to 21.7) |
Patients with symptoms for >6 months | 17 (12 to 22) | 16.3 (11.2 to 21.4) | 16.5 (11 to 22.1) | 18.6 (13 to 24.2) |
P value | 0.31 | 0.86 | 0.94 | 0.91 |
Oswestry Disability Index | ||||
Patients with symptomsfor ≤6 months | −17.2 (−19.9 to −14.6) | −15 (−17.7 to −12.3) | −5 (−17.8 to −12.2) | −16.3 (−19.2 to −13.4) |
Patients with symptoms for >6 months | −18.1 (−22.2 to −14) | −16.7 (−20.8 to −12.5) | −16.9 (−21.4 to −12.4) | −16.1 (−20.6 to −11.6) |
P value | 0.72 | 0.5 | 0.46 | 0.96 |
CI = confidence interval.